Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5160 participants.
Also called NCT05182970
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 5,160 participants
- Registry
-
NCT05182970
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Unknown status
Technical summary
Registry record NCT05182970. Randomized; no masking; primary purpose prevention. Start 2021-12-02 (actual); primary completion 2026-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
- Acronym
- MIMET
- Condition
- PreDiabetes
- Condition
- Acute Myocardial Infarction
- Condition
- Non ST Elevation Myocardial Infarction
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Drug)
- Metformin
- Lead sponsor
- Karolinska Institutet
- Collaborator
- St Goran's Hospital
- Collaborator
- Uppsala University
- Collaborator
- The Swedish Research Council
Record details
- Record id
cardio:ct-nct05182970- Content hash
08878a83014bc35bee00efe1ca9e4634b1209a428c8e703dbd17a0ec4d0d54ae